Related references
Note: Only part of the references are listed.Inhaled Treprostinil in Pulmonary Hypertension Due to Interstitial Lung Disease
Aaron Waxman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Plasma markers in pulmonary hypertension subgroups correlate with patient survival
T. Koudstaal et al.
RESPIRATORY RESEARCH (2021)
PDGFRα and αSMA mark two distinct mesenchymal cell populations involved in parenchymal and vascular remodeling in pulmonary fibrosis
Valentina Biasin et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2020)
The Trouble With Group 3 Pulmonary Hypertension in Interstitial Lung Disease Dilemmas in Diagnosis and the Conundrum of Treatment
Christopher S. King et al.
CHEST (2020)
STAT1-p53-p21axis-dependent stress-induced progression of chronic nephrosis in adriamycin-induced mouse model
Hua Wei et al.
ANNALS OF TRANSLATIONAL MEDICINE (2020)
Machine Learning Analysis of the Bleomycin Mouse Model Reveals the Compartmental and Temporal Inflammatory Pulmonary Fingerprint
Natalie Bordag et al.
ISCIENCE (2020)
CDK4/6 inhibition enhances pulmonary inflammatory infiltration in bleomycin-induced lung fibrosis
Anna Birnhuber et al.
RESPIRATORY RESEARCH (2020)
Adenosine and hyaluronan promote lung fibrosis and pulmonary hypertension in combined pulmonary fibrosis and emphysema
Scott D. Collum et al.
DISEASE MODELS & MECHANISMS (2019)
Serum CXCL9 and CCL17 as biomarkers of declining pulmonary function in chronic bird-related hypersensitivity pneumonitis
Yoshihisa Nukui et al.
PLOS ONE (2019)
Comorbidities in idiopathic pulmonary fibrosis: an underestimated issue
Antonella Caminati et al.
EUROPEAN RESPIRATORY REVIEW (2019)
Protective role of NKT cells and macrophage M2-driven phenotype in bleomycin-induced pulmonary fibrosis
Felipe Grabarz et al.
INFLAMMOPHARMACOLOGY (2018)
Myeloid-derived Suppressor Cells Are Necessary for Development of Pulmonary Hypertension
Andrew J. Bryant et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2018)
Dominant Role for Regulatory T Cells in Protecting Females Against Pulmonary Hypertension
Rasa Tamosiuniene et al.
CIRCULATION RESEARCH (2018)
The inflammatory cell landscape in the lungs of patients with idiopathic pulmonary arterial hypertension
Leigh M. Marsh et al.
EUROPEAN RESPIRATORY JOURNAL (2018)
Resident cell lineages are preserved in pulmonary vascular remodeling
Slaven Crnkovic et al.
JOURNAL OF PATHOLOGY (2018)
JAK2 mediates lung fibrosis, pulmonary vascular remodelling and hypertension in idiopathic pulmonary fibrosis: an experimental study
Javier Milara et al.
THORAX (2018)
Comparison of short-term outcomes for connective tissue disease-related interstitial lung disease and idiopathic pulmonary fibrosis after lung transplantation
Ji Eun Park et al.
JOURNAL OF THORACIC DISEASE (2018)
Myeloperoxidase aggravates pulmonary arterial hypertension by activation of vascular Rho-kinase
Anna Klinke et al.
JCI INSIGHT (2018)
The Role of Neutrophils and Neutrophil Elastase in Pulmonary Arterial Hypertension
Shalina Taylor et al.
FRONTIERS IN MEDICINE (2018)
Inhibition of hyaluronan synthesis attenuates pulmonary hypertension associated with lung fibrosis
Scott D. Collum et al.
BRITISH JOURNAL OF PHARMACOLOGY (2017)
Arterial stiffness induces remodeling phenotypes in pulmonary artery smooth muscle cells via YAP/TAZ-mediated repression of cyclooxygenase-2
Paul B. Dieffenbach et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2017)
Macrophage bone morphogenic protein receptor 2 depletion in idiopathic pulmonary fibrosis and Group III pulmonary hypertension
Ning-Yuan Chen et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2016)
Activated prostaglandin D2 receptors on macrophages enhance neutrophil recruitment into the lung
Katharina Jandl et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2016)
Vascular stiffness mechanoactivates YAP/TAZ-dependent glutaminolysis to drive pulmonary hypertension
Thomas Bertero et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Immunomodulation by mesenchymal stem cells in treating human autoimmune disease-associated lung fibrosis
Ming Liu et al.
STEM CELL RESEARCH & THERAPY (2016)
Chymase: a multifunctional player in pulmonary hypertension associated with lung fibrosis
Djuro Kosanovic et al.
EUROPEAN RESPIRATORY JOURNAL (2015)
Deletion of ADORA2B from myeloid cells dampens lung fibrosis and pulmonary hypertension
Harry Karmouty-Quintana et al.
FASEB JOURNAL (2015)
STAT1 deficiency redirects IFN signalling toward suppression of TLR response through a feedback activation of STAT3
Hun Sik Kim et al.
SCIENTIFIC REPORTS (2015)
Type II nKT cells in inflammation, autoimmunity, microbial immunity, and cancer
Idania Marrero et al.
FRONTIERS IN IMMUNOLOGY (2015)
Distinct Differences in Gene Expression Patterns in Pulmonary Arteries of Patients with Chronic Obstructive Pulmonary Disease and Idiopathic Pulmonary Fibrosis with Pulmonary Hypertension
Julia Hoffmann et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2014)
C-X-C Motif Chemokine 13 (CXCL13) Is a Prognostic Biomarker of Idiopathic Pulmonary Fibrosis
Louis J. Vuga et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2014)
Cytotoxic Cells and Granulysin in Pulmonary Arterial Hypertension and Pulmonary Veno-occlusive Disease
Frederic Perros et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2013)
Adenosine A2B Receptor and Hyaluronan Modulate Pulmonary Hypertension Associated with Chronic Obstructive Pulmonary Disease
Harry Karmouty-Quintana et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2013)
Invariant natural killer T (iNKT) cell exhaustion in sarcoidosis
Jennifer E. Snyder-Cappione et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2013)
Vascular remodeling in pulmonary hypertension
Larissa A. Shimoda et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2013)
Modern Age Pathology of Pulmonary Arterial Hypertension
Elvira Stacher et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2012)
Immune and Inflammatory Cell Involvement in the Pathology of Idiopathic Pulmonary Arterial Hypertension
Rajkumar Savai et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2012)
Gene Expression Profiling in the Lungs of Patients With Pulmonary Hypertension Associated With Pulmonary Fibrosis
Marco Mura et al.
CHEST (2012)
Impaired Natural Killer Cell Phenotype and Function in Idiopathic and Heritable Pulmonary Arterial Hypertension
Mark L. Ormiston et al.
CIRCULATION (2012)
IL-15 Regulates Homeostasis and Terminal Maturation of NKT Cells
Laura E. Gordy et al.
JOURNAL OF IMMUNOLOGY (2011)
Pulmonary Vascular Wall Stiffness: An Important Contributor to the Increased Right Ventricular Afterload with Pulmonary Hypertension
Zhijie Wang et al.
Pulmonary Circulation (2011)
CXC-Chemokine Ligand 10 in Idiopathic Pulmonary Arterial Hypertension: Marker of Improved Survival
Gustavo A. Heresi et al.
LUNG (2010)
Interleukin-6 Overexpression Induces Pulmonary Hypertension
M. Kathryn Steiner et al.
CIRCULATION RESEARCH (2009)
Echocardiography and brain natriuretic peptide as prognostic indicators in idiopathic pulmonary fibrosis
Jin Woo Song et al.
RESPIRATORY MEDICINE (2009)
Pulmonary hypertension in patients with pulmonary fibrosis awaiting lung transplant
A. F. Shorr et al.
EUROPEAN RESPIRATORY JOURNAL (2007)
Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis
CJ Lettieri et al.
CHEST (2006)
Susceptibility of signal transducer and activator of transcription-1-deficient mice to pulmonary fibrogenesis
DM Walters et al.
AMERICAN JOURNAL OF PATHOLOGY (2005)
Treatment with α-galactosylceramide attenuates the development of bleomycin-induced pulmonary fibrosis
T Kimura et al.
JOURNAL OF IMMUNOLOGY (2004)
A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis
G Raghu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Inhibition of pulmonary fibrosis by the chemokine IP-10/CXCL10
AM Tager et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2004)
ENA-78 is an important angiogenic factor in idiopathic pulmonary fibrosis
MP Keane et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2001)
Molecular mechanisms of TGF-β antagonism by interferon γ and cyclosporine A in lung fibroblasts
O Eickelberg et al.
FASEB JOURNAL (2001)
Share Paper
